Oxidative Stress Assay Market: By Product, By Test Type, By Technology Type, Flow Cytometry, Chromatography, Microscopy, and Others), By Disease Type, and Cancer), and Geography
Oxidative Stress Assay Market size was estimated at US$ 1,283.4 million in 2023 and is poised to grow at a CAGR of 8.7% from 2024 to 2030. The oxidative stress assay market is the global market for assays and techniques for measuring oxidative stress levels in biological samples. Oxidative stress occurs when there is an imbalance between free radicals (reactive oxygen species) and antioxidants in the body, leading to damage to cells, proteins, and DNA. This imbalance is implicated in various diseases including cancer, cardiovascular diseases, neurodegenerative disorders, and ageing. The upcoming years are likely to witness a notable expansion in the oxidative stress assay market. This growth is propelled by rising incidence of oxidative stress-related diseases, heightened research and development endeavours by pharmaceutical firms and research institutions, and technological innovations in assays for oxidative stress.
Additionally, supportive efforts by major industry players and governmental organizations to alleviate disease burdens are expected to spur research efforts, consequently boosting the global demand for oxidative stress assays. The anticipated rise in the oxidative stress assay market is fueled by the growing incidence of diseases correlated with oxidative stress, including cardiovascular diseases, respiratory conditions, oncological disorders, diabetes, and more. A study released by the Institute for Health Metrics and Evaluation in April 2023 revealed a global prevalence of approximately 454.6 million cases of chronic respiratory illnesses such as COPD, pneumoconiosis, asthma, and similar conditions. However, these instruments are equipped with advanced features and functionalities and thus are priced at a premium. For instance, a confocal microscope used in HCS can cost up to US$ 250,000. Additionally, variability and complexity of oxidative stress biomarkers also acts as a restraint of the oxidative stress assay market.
Study Period
2024-2030Base Year
2023CAGR
8.7%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The need for oxidative stress assays is being driven by the increased prevalence of chronic diseases, including diabetes, cancer, cardiovascular disease, and neurological disorders. Since oxidative stress plays a role in the aetiology of various illnesses, there is increased interest in evaluating oxidative stress indicators for prognosis, therapy monitoring, and illness diagnosis. 6 out of 10 adults in the United States are living with chronic illness, and 4 out of 10 adults are experiencing two or more disorders, according to the Centers for Disease Control and Prevention’s (CDC) May 2022 report. Age-related diseases and ailments linked to oxidative stress are on the rise worldwide as the population ages. Due to lowered antioxidant defences and cellular repair systems, elderly people are more vulnerable to oxidative damage. The need for oxidative stress tests in the management and prevention of age-related diseases is fueled by the increasing number of senior people. Growing knowledge of the part oxidative stress plays in the onset and course of disease is fueling the need for preventive healthcare measures. To detect oxidative stress levels early and facilitate dietary adjustments, antioxidant supplements, and lifestyle changes for disease prevention and health promotion, consumers are actively seeking diagnostic tests and biomarker evaluations. Assay technologies, including spectrophotometry, chromatography, immunoassays, and molecular biology techniques, continue to progress, resulting in the creation of increasingly sensitive, focused, and high-throughput tests for oxidative stress. Growth in the market is fueled by these technical advancements that increase assay efficiency, repeatability, and accuracy.
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 1,283.4 million |
|
Market CAGR |
8.7% |
|
By Product |
|
|
By Test Type |
|
|
By Technology |
|
|
By Disease Type |
|
Download Free Sample Report
The global oxidative stress assay market size was estimated at US$ 1,283.4 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.
Asia Pacific region accounts for the highest rate of growth in the oxidative stress assay market.
The major players in the oxidative stress assay market are Merck KGaA, Thermo Fisher Scientific, Inc., QIAGEN N.V., Abcam, plc, Enzo Life Sciences Inc., AMS Biotechnology Ltd., Cell Biolabs, Inc., Oxford Biomedical Research, Promega Corporation, ImmunoChemistry Technologies, Cayman Chemical, Eagle Biosciences, Inc., Arbor Assays, Hycult Biotech, Callegari SRL, and Kamiya Biomedical Company.
The key drivers of the oxidative stress assay market include the rising prevalence of oxidative stress-related diseases and disorders, increasing research and development activities, technological advancements in assay techniques, and growing awareness about the importance of oxidative stress in health and disease.
Key factors hampering the growth of the oxidative stress assay market include limitations in assay sensitivity and specificity, high costs associated with assay development and implementation, and challenges in standardization and validation of assay protocols.
| 1.Executive Summary |
| 2.Global Oxidative Stress Assay Market Introduction |
| 2.1.Global Oxidative Stress Assay Market - Taxonomy |
| 2.2.Global Oxidative Stress Assay Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Test Type |
| 2.2.3.Technology |
| 2.2.4.Disease Type |
| 2.2.5.Region |
| 3.Global Oxidative Stress Assay Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Oxidative Stress Assay Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Oxidative Stress Assay Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Instrument |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Consumables |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Services |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Oxidative Stress Assay Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Indirect Assays |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Antioxidant Capacity Assays |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Enzyme Based Assays |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Reactive Oxygen Species Based Assays |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Oxidative Stress Assay Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Enzyme-Linked Immunosorbent Assay (Elisa) |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Flow Cytometry |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Chromatography |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Microscopy |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Others |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.Global Oxidative Stress Assay Market By Disease Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Cardiovascular Disease |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Chronic Obstructive Pulmonary Disease (COPD) |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Cancer |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Global Oxidative Stress Assay Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia Pacific (APAC) |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Middle East and Africa (MEA) |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Latin America |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 10.North America Oxidative Stress Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Instrument |
| 10.1.2.Consumables |
| 10.1.3.Services |
| 10.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Indirect Assays |
| 10.2.2.Antioxidant Capacity Assays |
| 10.2.3.Enzyme Based Assays |
| 10.2.4.Reactive Oxygen Species Based Assays |
| 10.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Enzyme-Linked Immunosorbent Assay (Elisa) |
| 10.3.2.Flow Cytometry |
| 10.3.3.Chromatography |
| 10.3.4.Microscopy |
| 10.3.5.Others |
| 10.4. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Cardiovascular Disease |
| 10.4.2.Chronic Obstructive Pulmonary Disease (COPD) |
| 10.4.3.Cancer |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.5.1.United States of America (USA) |
| 10.5.2.Canada |
| 11.Europe Oxidative Stress Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Instrument |
| 11.1.2.Consumables |
| 11.1.3.Services |
| 11.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Indirect Assays |
| 11.2.2.Antioxidant Capacity Assays |
| 11.2.3.Enzyme Based Assays |
| 11.2.4.Reactive Oxygen Species Based Assays |
| 11.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Enzyme-Linked Immunosorbent Assay (Elisa) |
| 11.3.2.Flow Cytometry |
| 11.3.3.Chromatography |
| 11.3.4.Microscopy |
| 11.3.5.Others |
| 11.4. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.Cardiovascular Disease |
| 11.4.2.Chronic Obstructive Pulmonary Disease (COPD) |
| 11.4.3.Cancer |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.5.1.Germany |
| 11.5.2.France |
| 11.5.3.Italy |
| 11.5.4.United Kingdom (UK) |
| 11.5.5.Spain |
| 12.Asia Pacific (APAC) Oxidative Stress Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Instrument |
| 12.1.2.Consumables |
| 12.1.3.Services |
| 12.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Indirect Assays |
| 12.2.2.Antioxidant Capacity Assays |
| 12.2.3.Enzyme Based Assays |
| 12.2.4.Reactive Oxygen Species Based Assays |
| 12.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Enzyme-Linked Immunosorbent Assay (Elisa) |
| 12.3.2.Flow Cytometry |
| 12.3.3.Chromatography |
| 12.3.4.Microscopy |
| 12.3.5.Others |
| 12.4. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.Cardiovascular Disease |
| 12.4.2.Chronic Obstructive Pulmonary Disease (COPD) |
| 12.4.3.Cancer |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.5.1.China |
| 12.5.2.India |
| 12.5.3.Australia and New Zealand (ANZ) |
| 12.5.4.Japan |
| 12.5.5.Rest of APAC |
| 13.Middle East and Africa (MEA) Oxidative Stress Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Instrument |
| 13.1.2.Consumables |
| 13.1.3.Services |
| 13.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Indirect Assays |
| 13.2.2.Antioxidant Capacity Assays |
| 13.2.3.Enzyme Based Assays |
| 13.2.4.Reactive Oxygen Species Based Assays |
| 13.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Enzyme-Linked Immunosorbent Assay (Elisa) |
| 13.3.2.Flow Cytometry |
| 13.3.3.Chromatography |
| 13.3.4.Microscopy |
| 13.3.5.Others |
| 13.4. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Cardiovascular Disease |
| 13.4.2.Chronic Obstructive Pulmonary Disease (COPD) |
| 13.4.3.Cancer |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.5.1.GCC Countries |
| 13.5.2.South Africa |
| 13.5.3.Rest of MEA |
| 14.Latin America Oxidative Stress Assay Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1.Instrument |
| 14.1.2.Consumables |
| 14.1.3.Services |
| 14.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1.Indirect Assays |
| 14.2.2.Antioxidant Capacity Assays |
| 14.2.3.Enzyme Based Assays |
| 14.2.4.Reactive Oxygen Species Based Assays |
| 14.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.3.1.Enzyme-Linked Immunosorbent Assay (Elisa) |
| 14.3.2.Flow Cytometry |
| 14.3.3.Chromatography |
| 14.3.4.Microscopy |
| 14.3.5.Others |
| 14.4. Disease Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.4.1.Cardiovascular Disease |
| 14.4.2.Chronic Obstructive Pulmonary Disease (COPD) |
| 14.4.3.Cancer |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 14.5.1.Brazil |
| 14.5.2.Mexico |
| 14.5.3.Rest of LA |
| 15. Competition Landscape |
| 15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 15.2.1.Merck KGaA |
| 15.2.2.Thermo Fisher Scientific, Inc. |
| 15.2.3.QIAGEN N.V. |
| 15.2.4.Abcam, plc |
| 15.2.5.Enzo Life Sciences Inc. |
| 15.2.6.AMS Biotechnology Ltd. |
| 15.2.7.Cell Biolabs, Inc. |
| 15.2.8.Oxford Biomedical Research |
| 15.2.9.Promega Corporation |
| 15.2.10.ImmunoChemistry Technologies |
| 15.2.11.Cayman Chemical |
| 15.2.12.Eagle Biosciences, Inc. |
| 15.2.13.Arbor Assays |
| 15.2.14.Hycult Biotech |
| 15.2.15.Callegari SRL |
| 15.2.16.Kamiya Biomedical Company |
| 16. Research Methodology |
| 17. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
